| Product NDC: | 0781-3040 |
| Proprietary Name: | Regonol |
| Non Proprietary Name: | Pyridostigmine Bromide |
| Active Ingredient(s): | 5 mg/mL & nbsp; Pyridostigmine Bromide |
| Administration Route(s): | INTRAVENOUS; PARENTERAL |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0781-3040 |
| Labeler Name: | Sandoz Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017398 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050510 |
| Package NDC: | 0781-3040-95 |
| Package Description: | 10 AMPULE in 1 CARTON (0781-3040-95) > 2 mL in 1 AMPULE (0781-3040-72) |
| NDC Code | 0781-3040-95 |
| Proprietary Name | Regonol |
| Package Description | 10 AMPULE in 1 CARTON (0781-3040-95) > 2 mL in 1 AMPULE (0781-3040-72) |
| Product NDC | 0781-3040 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pyridostigmine Bromide |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS; PARENTERAL |
| Start Marketing Date | 20050510 |
| Marketing Category Name | NDA |
| Labeler Name | Sandoz Inc |
| Substance Name | PYRIDOSTIGMINE BROMIDE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |